Iopamiro

Iopamidol, the active ingredient in Iopamiro, is a iodinated contrast media presented as a solution for injection for intraarterial, intraarticular and intrathecal use. It enhances X‑ray attenuation, improving visualization of vascular and tissue structures during imaging procedures.

GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, diagnostic centres and imaging clinics worldwide, ensuring EU‑standard quality and reliable global distribution.

Iopamiro is an iodinated contrast medium used in diagnostic imaging procedures that require enhanced visualization of vascular, joint and spinal structures.

- Angiography: provides high‑contrast images of blood vessels to aid in vascular assessment. - Arthrography: improves delineation of joint spaces and cartilage for orthopedic evaluation. - Myelography: enhances visualization of the spinal canal and nerve roots during contrast‑enhanced spinal imaging.

Iopamiro may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Warm sensation or flushing at the injection site - Metallic taste in the mouth - Nausea or mild headache

Serious or Rare Side Effects: - Severe allergic reactions, including anaphylaxis - Acute kidney injury in susceptible patients - Cardiovascular collapse or hypotension

When using Iopamiro, clinicians should observe several safety measures.

- Renal function: assess baseline kidney function and adjust dose in impaired patients. - Allergy history: screen for previous reactions to iodinated contrast agents. - Thyroid status: monitor patients with hyperthyroidism as iodine load may exacerbate condition. - Pregnancy: use only when essential after risk‑benefit evaluation. - Concomitant nephrotoxic drugs: avoid or monitor when combined with NSAIDs, aminoglycosides, or radiographic contrast. - Store at controlled room temperature: keep below 25 °C in original container, protect from light and moisture.

Iopamiro can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in renal impairment; discontinue before procedure. - NSAIDs: may increase risk of contrast‑induced nephropathy. - Diuretics: can exacerbate renal dysfunction when combined with contrast.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may affect renal perfusion; monitor kidney function. - Iodine‑containing medications: potential additive iodine load. - Radiopharmaceuticals: consider timing to avoid interference.